Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant.
Leivestad
T
T
Institute of Transplantation Immunology, National Hospital, Rikshopitalet, Oslo, Norway.
Berger
L
L
Thorsby
E
E
D016572:Cyclosporine / Q000008:administration & dosage; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology* / Q000401:mortality; D006085:Graft Survival / Q000276:immunology*; D015234:HLA-A Antigens / Q000276:immunology; D015235:HLA-B Antigens / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D009664:Norway; D011183:Postoperative Complications / Q000276:immunology* / Q000401:mortality; D015996:Survival Rate
D015234:HLA-A Antigens; D015235:HLA-B Antigens; D006684:HLA-DR Antigens; D016572:Cyclosporine